Six derivatives of guttiferone-A 80, 81, 82, 113 and 114) were synthesized and evaluated for their antimicrobial activity against the opportunistic or pathogenic fungi Candida albicans (ATCC 09548), Candida glabrata (ATCC 90030), Candida krusei (ATCC 6258), Candida parapsilosis (ATCC 69548), Candida tropicalis (ATCC 750), Cryptococcus neoformans (ATCC 90012), Trichophyton tonsurans, Microsporum gypseum and also against the opportunistic and pathogenic Gram-positive bacteria Staphylococcus aureus (ATCC 6538), Staphylococcus epidermidis (ATCC 12228), Bacillus cereus (ATCC 11778) and Gram-negative Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 9027), Salmonella typhimurium (ATCC 14028), Proteus mirabilis (ATCC 25933). The antimicrobial activities of derivatives were compared with guttiferone-A and they presented to be more potent than the original molecule and sometimes greater than standard drugs established in therapeutics. The current study showed that derivatives of guttiferone-A possess potent antimicrobial activity and are relatively non-cytotoxic, which reveal these new molecules as promising new drug prototype candidates, with innovative structural pattern.
Introduction
Infectious diseases represent a critical issue for health and are the major cause of morbidity and mortality worldwide. Despite significant progress in human medicine, infectious diseases caused by microorganisms are still a serious threat to public health. The impact is even greater in developing countries due to unavailability of medicine in all locations, the practice of self-medication and the emergence of microorganism drug resistance. 1 The polyisoprenylated benzophenone derivatives compounds are a very restricted class of plant natural products, occurring mainly in the family Guttiferae that excels due to benzophenones usually replaced by isoprenyl or geranyl subunits, which can be cyclized or not. For several polyisoprenylated benzophenones, antimicrobial, cytotoxic, antiviral, antioxidant and antiinflammatory activities have been reported. 2 The species Garcinia brasiliensis is native to the Amazon region and is cultivated throughout the Brazilian territory and is known as 'bacupari'. It is a tree of medium size that blooms from August to September and presents a yellow fruit with a white and edible mucilaginous pulp. In folk medicine, the leaves of G. brasiliensis are used to treat tumors, inflammation of the urinary tract, arthritis and to relieve pain. 3 Guttiferone-A (1) is one of the most abundant natural polyisoprenylated benzophenone isolated from G. brasiliensis, and many pharmacological activities have been reported for this metabolite, including anti-HIV, 4 cytotoxic, 5 trypanocidal, antiplasmodial, antioxidant, 6 inhibitory activity of cysteine and serine proteases, 7 and antimicrobial. 8, 9 In a continuing search for new antimicrobial drug candidates, we elected compound 1, that had already showed antimicrobial activities, 8, 9 as a model for molecular modifications aiming the preparation of more potent derivatives and the establishment of a structure-activity relationship and evaluate the contributions of functional group modifications in the lipophilicity of the target derivatives. Hydroxyl groups at C-13 and C-14 positions were focused for chemical modifications based on their higher reactivity and on previous data 10 that indicates the importance of the chelatogenic system on ring B for biological activity. Thus, in this report we present the semisynthetic preparation of a series of six new derivatives of natural guttiferone-A (1), isolated from the seeds of G. brasiliensis, and the results of their antimicrobial evaluation.
Results and discussion

Semisynthesis of guttiferone-A derivatives
The synthesis of guttiferone-A (1) derivatives LFQM-79 (2), LFQM-80 (3), LFQM-81 (4), LFQM-82 (5), LFQM-113 (6) and LFQM-114 (7) are shown in Figure 1 Tables 5 and 6 .
In order to synthesize compound LFQM-79 (2), guttiferone-A (1) was reacted with di-tert-butoxycarbonyl anhydride and 4-DMAP in CH 2 2 and two bands at 1103.28 and 738.74 cm À1 attributed to the axial strain of the group SOC. The absence of the band related to phenolic hydroxyl groups at 3485 cm À1 suggested the replacement of two hydroxyl groups of the substrate 1. On the basis of these spectroscopic data, compound LFQM-81 was identified as 13,14-di-methanesulfonyl-guttiferone-A (4).
Compound LFQM-82 (5) was prepared by reaction of compound 1 with chlorobenzoyl chloride and K 2 CO 3 in acetone. The molecular weight of compound 5 was determined by HRESI-MS to be 901. Based on the absence of bands for axial deformation of OH group in the IR spectrum, it was presumed that all phenolic hydroxyl groups were substituted. Characteristic bands were observed at 1749 cm À1 and 1253 cm À1 , corresponding to axial deformations of C@O and C-O-C@O of the ester group.
The UV spectrum displayed absorptions with k máx (log e) at 244 nm (4.21) for the pure compound. Addition of AlCl 3 led to absorptions at 468 nm (2.27) and 244 nm (4.18). Addition of HCl produced absorptions at 468 nm (2.04) and 227 nm (4.12). Again, these shift changes in the UV absorption produced by adding AlCl 3 and HCl revealed that the chelatogenic hydroxyl group at C-4 position was preserved. According to these spectroscopic data, compound LFQM-82 was confirmed as 13,14-di-chlorobenzoylguttiferone-A (5).
Compound LFQM-113 (6) was obtained by reaction of compound 1 with p-toluenesulfonyl chloride and triethylamine in CH 2 Cl 2 . The molecular weight of compound 6 was determined by HRESI-MS to be 933.3645 [M+Na] + , consistent with a molecular formula of C 52 H 62 O 10 S 2 Na. The formation of tosyl ester was evidenced in the IR spectrum by the absorption bands at 1749 cm À1 and 1246 cm À1 characteristic of axial deformations of C@O of ester and C-O-C@O, respectively. The formation of the tosyl-guttiferone derivative was also confirmed by 1 H and 13 C NMR.
In the lower field region of 13 .78 showed indicated that the two phenolic hydroxyl groups of the substrate were converted to the di-benzoyl ester derivative. Furthermore, this conversion was also supported by the carbonyl peak at 1719 cm À1 observed in the IR spectrum.
Shifts in the UV spectrum produced by adding AlCl 3 and HCl indicated the presence of a chelatogenic hydroxyl group. The UV spectrum displayed absorptions with k máx (log e) at 339 nm (1.88), 233 nm (3.76) and 206 nm (3.56), for the pure compound. Adding AlCl 3 produced absorptions at 333 nm (2.52), 232 nm (3.84) and 207 nm (3.64). Addition of HCl produced absorptions at 335 nm (2.44), 231 nm (3.87) and 206 nm (3.73) indicating that the reaction did not occur at the hydroxyl group attached to C-4. On the basis of these spectroscopic data compound LFQM-114 was identified as 13,14-di-benzoyl-guttiferone-A (7).
Evaluation of lipophilicity
The lipophilicity of compounds 1-7 were estimated by theoretical calculation of partition coefficient octanol/water (c Log P oct/ wat). The values are shown in Table 1 , and clearly indicate that substituted sulfonyl groups, independent of their volume and size, contributed to reduce c Log P (oct/wat).
Antimicrobial assay
Guttiferone-A (1) and its derivatives 2-7 were evaluated for their antimicrobial activities. The results of antimicrobial assays against a panel of selected Gram-positive, Gram-negative bacteria and fungi are reported in Table 2 and 3, along with those of reference drugs chloramphenicol and amphotericin B. DMSO used as vehicle did not show any effect on bacteria and fungi.
The semisynthetic derivatives 2-7 exhibited a significant action against Gram-positive S. aureus and B. cereus. For S. aureus, compounds guttiferone-A (1), LFQM-79 (2), LFQM-80 (3), LFQM-81 (4), and LFQM-113 (6) were the most active, with prominent results for compounds 1, 3, 4 and 6 exhibiting a potency of 1.45-, 3.31-, 3.66-and 4.39-fold, respectively, more active than the standard drug chloramphenicol. Furthermore, compounds 3, 4 and 6 were about 2.5 times more active than the natural prototype 1, showing that the modifications carried out on these derivatives were very important for activity modulation. Against S. epidermidis, only compound 6 showed activity 3.5-fold greater than that of chloramphenicol. For B. cereus, only compound 7 was not active, and all other derivatives were more active than chloramphenicol, with compounds 3 and 4 showing to be 9.13 and 1.25-fold more active, respectively, than the natural prototype 1.
For Gram-negative microorganisms, all compounds tested showed a lower activity profile, with the majority of them exhibiting only bacteriostatic properties. Compounds 2 and 7 were active against P. aeruginosa, while compounds 1, 2 and 5 showed better fungistatic results against S. typhimurium, in comparison to chloramphenicol used as standard drug. On the other hand, compounds 2, 4, 5 and 7 were the most active against E. coli, showing to be bacteriostatic agents, while only compounds 1 and 5 were active against P. mirabilis, in spite of derivative 5 have showed lower activity than chloramphenicol.
Differences in the composition of the cell wall of Gram-positive and Gram-negative bacteria and a possible relationship with the lipophilic characteristics of the target molecules could be helpful to explain the difference of these antibacterial compounds. Gram-positive bacteria possess only one discrete membrane composition: acidic polysaccharides (teichoic acids) and negatively charged phospholipids. In contrast, Gram-negative bacteria present two membranes with different chemical constituents: the outer membrane containing lipopolysaccharides and the inner membrane containing negatively charged phospholipids.
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Considering the results obtained for guttiferone-A (1) and its derivatives 2-7, it is possible to note that compounds 3, 4 and 6 were the most active against Gram-positive bacteria, and that these molecules exhibit the lowest c Log P (oct/wat) value, with lipophilicity of 9.06, 5.20 and 8.75, respectively. As for Gram-negative compounds LFQM-79, 82 and 114 that were active against some Gram-positive bacteria showed higher bactericidal activity than the other compounds. Despite of the reduced number of analogs, a comparative analysis of the theoretical lipophilicity of antibacterial derivatives was indicative that variation in lipophilicity could be an important requisite for modulation of the activity and, as reported in the literature, 12 compounds with higher hydrophilicity are more active against Gram-positive, while a higher lipophilicity favors the activity against Gram-negative. However, the correlation between lipophilicity and antimicrobial activity should be confirmed experimentally and does not exclude the importance of other structural factors that may be responsible for the activity of this series of compounds. Among all compounds tested against yeast, only the natural prototype 1 showed significant fungistatic activity in comparison to Fluconazole and Amphotericin B used as standard drugs. All other derivatives were not active or showed poor activity, revealing that the phenolic hydroxyl group is a pharmacophoric subunit. For C. neoformans and dermatophytes T. mentagrophytes and M. gypseum the prominent derivatives were compounds 2 and 3 that showed better antifungal activity than the natural benzophenone 1, showing that the insertion of carbonyl functional groups, like an ester or carbonate, could be auxophoric for the activity. There was not evidenced any correlation between c Log P (oct/wat) and antifungal activity among all tested derivatives.
Cell viability assay
Cell viability was assessed by MTT reduction assay that is a rapid and objective assay used to evaluate cellular cytotoxicity, based on a colorimetric reaction. The values of the cytotoxic concentration (CC 50 ) are showed in Table 4 and revealed that all derivatives exhibited higher values of minimum inhibitor concentration (MIC) required for inhibiting the growth of bacteria and fungi tested, demonstrating that compound 1 and the derivatives 2-7 are selective and less toxic compounds.
Experimental section
General
The 1D NMR spectra were performed on a Varian MR-400 spectrometer, operating at 400 MHz for 1 H NMR and 100 MHz for 13 C NMR, using CDCl 3 as solvent. Chemical shifts are reported in parts per million (ppm) with reference to tetramethylsilane (TMS). The coupling constants are reported in hertz (Hz) and signal multiplicities are reported as singlet (s), doublet (d), doublet of doublet (dd), (5) >113.85 LFQM-113 (6) >113.33 LFQM-114 (7) >123.39 mulitplet (m). Absorption spectra in the infrared region (IR) were obtained with a Prestige-21 spectrometer using KBr pellets. Separations by column chromatography were carried out with Silica Gel 60 (60-200 mesh, Merck) and TLC experiments were carried out on Silica gel 60 F254, supported in aluminum plates (0.2 mm, Merck). Absorption spectra in the ultraviolet region were collected with a Shimadzu-2550 dual beam UV-visible spectrophotometer, as described by Mabry et al. 13 with modifications. The phenolic constituents were dissolved in ethanol (0.1%) and analyzed by scanning over the range k = 500-200 nm, followed by the addition of AlCl 3 and HCl. All chemicals and solvents were used without prior treatment, except for anhydrous reactions when solvents were dried according to the literature.
The fruits of G. brasiliensis were collected from species cultivated at University of Viçosa, Minas Gerais, Brazil, where its voucher specimen is deposited under the number VIC2604.
Extraction and purification of guttiferone-A (1)
The seeds of G. brasiliensis were dried in air, powdered and extracted by percolation with ethyl acetate at room temperature for 24 h. The process was repeated until all the material has been extracted and the solvent was removed under reduced pressure to furnish a crude ethyl acetate extract (SEAE). SEAE was then 2 O and a catalytic amount of 4-DMAP were added. The mixture was stirred for a 12 h period at room temperature, until TLC analysis indicated total conversion. Next, 20 mL of H 2 O was added and the reaction mixture was extracted with CH 2 Cl 2 (3 Â 10 mL) and dried over MgSO 4 . The combined organic layers were evaporated and the reaction product was purified by column chromatography on silica gel using hexanes (9): ethyl acetate (1) Tables 5 and 6 .
Compound LFQM-80 (3)
To a solution of 0.17 mmol (100 mg) guttiferone-A (1) in CH 2 Cl 2 (5 mL), were added 1 mL (10.5 mmol) of acetic anhydride and catalytic amount of 4-DMAP. The system was kept under stirring at room temperature for 4 h, monitored by TLC. After reaction was complete, water were added (20 mL) to the mixture, the aqueous phase was extracted with ethyl acetate (3 Â 20 mL) and dried with sodium sulfate. The combined organic layers were concentrated and the crude product was purified by column chromatography on silica gel using hexanes (9) Tables 5   and 6 .
Compound LFQM-82 (5)
Guttiferone-A (1) (0.17 mmol) was dissolved in 5 mL acetone. Then, 0.34 mmol (47 mg) of K 2 CO 3 and 0.34 mmol (0.04 mL) of 4-ClBzCl were added in sequence. The reaction mixture was stirred at room temperature for a period of 4 h. After total conversion of the starting material (TLC), the reaction material was neutralized with aqueous saturated NaHCO 3 and extracted with ethyl acetate (3 Â 10 mL). The combined organic extracts were dried over MgSO 4 , evaporated and purified by preparative TLC using hexanes (9) Tables 5 and 6. 3.4.6. Compound LFQM-114 (7) 0.17 mmol (100 mg) of guttiferone-A (1) was dissolved in 5 mL of dried CH 2 Cl 2 . Then, 0.34 mmol (47.00 mg) of K 2 CO 3 and 0.34 mmol (0.04 mL) of BzCl were added in sequence. The reaction mixture was stirred at room temperature for a 12 h period. After total conversion of the starting material observed by TLC, two portions of 30 mL of CH 2 Cl 2 were added and the resultant solution was washed with aqueous saturated NaHCO 3 . The organic extract was dried over MgSO 4 , evaporated and purified by preparative TLC using hexanes (9. Tables 5   and 6 .
The evaluation of lipophilicity by c Log P (oct/water)
Lipophilicity values were estimated through determination theoretical of c Log P (oct/wat) by using the QikProp program. 15 The
QikProp program calculates the c Log P (oct/wat) values from regression equations using experimental data and molecule physical descriptors (hydrogen bond counts, atom types and charges, rotor counts, etc.) through Monte Carlo statistical mechanics simulations. 16 Calculated lipophilicity expressed by c Log P (oct/wat) of compounds 1-7 are showed on Table 1 .
Antimicrobial activity evaluation
Guttiferone-A (1) and its derivatives 2-7 were evaluated for their antimicrobial activities against the fungi through a standard RPMI medium with L-glutamine and morpholinepropanesulfonic acid buffer broth microdilution method proposed by document M27A3 (CLSI, 2008) 17 and supplemented with 2% dextrose to yeasts and document M38A2 (CLSI, 2003) 18 to filamentous fungi and a standard Mueller Hinton broth microdilution method for bacteria proposed by document M7A6 (CLSI, 2003). 19 The stock solutions of compounds 1-7 were prepared in DMSO 1% at final concentration and tested at concentrations (lg/mL) 100; 62. 
Cell viability assay
Cell viability was determined using a modified MTT assay with peripheral human blood mononuclear cells (PBMC) obtained from healthy volunteers by Ficoll-Hypaque density gradient centrifugation. The cell suspension of normal PBMC at a concentration of 2.4 Â 10
